JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 312 Million JPY | -77.47% |
| 2022 | 1.38 Billion JPY | 861.81% |
| 2021 | 144 Million JPY | 195.36% |
| 2020 | -151 Million JPY | 95.9% |
| 2019 | -3.67 Billion JPY | -184.75% |
| 2018 | -1.29 Billion JPY | -8.12% |
| 2017 | -1.19 Billion JPY | -194.32% |
| 2016 | 1.26 Billion JPY | 684.98% |
| 2015 | -216.58 Million JPY | -149.85% |
| 2014 | 434.5 Million JPY | 116.77% |
| 2013 | -2.59 Billion JPY | -8.24% |
| 2012 | -2.39 Billion JPY | -238.21% |
| 2011 | 1.73 Billion JPY | 229.8% |
| 2010 | 525.09 Million JPY | -43.89% |
| 2009 | 935.75 Million JPY | 206.78% |
| 2008 | 305.02 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 35 Million JPY | -88.78% |
| 2024 Q3 | -1.93 Billion JPY | -28.68% |
| 2024 Q2 | -1.5 Billion JPY | -4394.29% |
| 2023 Q2 | 3.77 Billion JPY | 14.13% |
| 2023 Q3 | 2.98 Billion JPY | -21.02% |
| 2023 Q4 | 312 Million JPY | -89.53% |
| 2023 FY | 312 Million JPY | -77.47% |
| 2023 Q1 | 3.3 Billion JPY | 138.7% |
| 2022 Q4 | 1.38 Billion JPY | 199.14% |
| 2022 FY | 1.38 Billion JPY | 861.81% |
| 2022 Q1 | 782 Million JPY | 443.06% |
| 2022 Q3 | 463 Million JPY | 183.27% |
| 2022 Q2 | -556 Million JPY | -171.1% |
| 2021 Q3 | 38 Million JPY | 135.19% |
| 2021 Q4 | 144 Million JPY | 278.95% |
| 2021 Q1 | 828 Million JPY | 648.34% |
| 2021 FY | 144 Million JPY | 195.36% |
| 2021 Q2 | -108 Million JPY | -113.04% |
| 2020 FY | -151 Million JPY | 95.9% |
| 2020 Q1 | -3.87 Billion JPY | -5.3% |
| 2020 Q4 | -151 Million JPY | -108.16% |
| 2020 Q3 | 1.85 Billion JPY | 2861.19% |
| 2020 Q2 | -67 Million JPY | 98.27% |
| 2019 Q2 | -1.9 Billion JPY | -40.32% |
| 2019 Q3 | -2.91 Billion JPY | -52.91% |
| 2019 Q4 | -3.67 Billion JPY | -26.17% |
| 2019 Q1 | -1.35 Billion JPY | -5.19% |
| 2019 FY | -3.67 Billion JPY | -184.75% |
| 2018 FY | -1.29 Billion JPY | -8.12% |
| 2018 Q2 | 224 Million JPY | 63.5% |
| 2018 Q3 | -513 Million JPY | -329.02% |
| 2018 Q4 | -1.29 Billion JPY | -151.85% |
| 2018 Q1 | 137 Million JPY | 111.46% |
| 2017 Q4 | -1.19 Billion JPY | 23.1% |
| 2017 Q1 | 414 Million JPY | -67.32% |
| 2017 Q2 | -869 Million JPY | -309.9% |
| 2017 Q3 | -1.55 Billion JPY | -78.83% |
| 2017 FY | -1.19 Billion JPY | -194.32% |
| 2016 FY | 1.26 Billion JPY | 684.98% |
| 2016 Q4 | 1.26 Billion JPY | -25.43% |
| 2016 Q3 | 1.69 Billion JPY | 4.23% |
| 2016 Q2 | 1.63 Billion JPY | 48.45% |
| 2016 Q1 | 1.09 Billion JPY | 606.95% |
| 2015 Q1 | 233.09 Million JPY | -46.35% |
| 2015 FY | -216.58 Million JPY | -149.85% |
| 2015 Q2 | 202.31 Million JPY | -13.2% |
| 2015 Q3 | -40.32 Million JPY | -119.93% |
| 2015 Q4 | -216.58 Million JPY | -437.17% |
| 2014 Q4 | 434.5 Million JPY | -18.62% |
| 2014 FY | 434.5 Million JPY | 116.77% |
| 2014 Q3 | 533.91 Million JPY | -17.75% |
| 2014 Q2 | 649.16 Million JPY | 195.97% |
| 2014 Q1 | 219.33 Million JPY | 108.47% |
| 2013 Q2 | -4.35 Billion JPY | -100.96% |
| 2013 Q3 | -4.6 Billion JPY | -5.73% |
| 2013 Q4 | -2.59 Billion JPY | 43.7% |
| 2013 Q1 | -2.16 Billion JPY | 9.51% |
| 2013 FY | -2.59 Billion JPY | -8.24% |
| 2012 Q4 | -2.39 Billion JPY | -188.89% |
| 2012 Q2 | 1.71 Billion JPY | -14.42% |
| 2012 Q1 | 2 Billion JPY | 15.69% |
| 2012 Q3 | 2.69 Billion JPY | 57.06% |
| 2012 FY | -2.39 Billion JPY | -238.21% |
| 2011 FY | 1.73 Billion JPY | 229.8% |
| 2011 Q3 | 1.53 Billion JPY | 98.34% |
| 2011 Q4 | 1.73 Billion JPY | 12.45% |
| 2011 Q1 | 1.2 Billion JPY | 128.98% |
| 2011 Q2 | 776.42 Million JPY | -35.43% |
| 2010 FY | 525.09 Million JPY | -43.89% |
| 2010 Q4 | 525.09 Million JPY | 47.34% |
| 2010 Q3 | 356.36 Million JPY | 0.0% |
| 2009 Q4 | 935.75 Million JPY | 0.0% |
| 2009 Q1 | 995.65 Million JPY | 0.0% |
| 2009 Q2 | 671.15 Million JPY | -32.59% |
| 2009 FY | 935.75 Million JPY | 206.78% |
| 2008 FY | 305.02 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -64950.007% |
| Ansell Limited | -54.99 Million USD | 667.305% |
| Ansell Limited | -55.1 Million USD | 666.243% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 954.955% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 296954.484% |
| Psykey, Inc. | 634.59 Thousand USD | -49065.371% |
| ConvaTec Group Plc | 1.2 Billion USD | 74.013% |
| ConvaTec Group Plc | 1.2 Billion USD | 74.05% |
| Encision Inc. | 1.29 Million USD | -24073.061% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -13413.999% |
| Innovative MedTech Inc. | 1.76 Million USD | -17579.698% |
| LifePoint, Inc. | -3.26 Million USD | 9658.762% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -6261.917% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -14331.082% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 720587.715% |
| Reflect Scientific, Inc. | -1.03 Million USD | 30235.989% |
| SmileDirectClub, Inc. | 778.67 Million USD | 59.932% |
| Sector 10, Inc. | 163 Thousand USD | -191311.043% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 174.721% |
| SheerVision, Inc. | 57.34 Thousand USD | -543937.385% |
| United Health Products, Inc. | 660.56 Thousand USD | -47132.008% |
| Vasamed, Inc. | 22.12 Thousand USD | -1410260.727% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -11757.622% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -40299.907% |